GlassScriptPhysician profile
Sanjay C Dhar
NPI 1811074586
$21,285.99
in general payments reported to CMS, 2019-2025
46 companies · $5,866 in 2025
The $5,866 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,087 · 2020: $1,010 · 2021: $1,572 · 2022: $2,442 · 2023: $3,566 · 2024: $3,743 · 2025: $5,866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $1,460 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,555.58 |
| Travel and Lodging | $1,459.65 |
| Education | $160.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,371.10 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Symplicity G3 |
| Abbott Laboratories | $2,590.30 | 2019-2025 | Cardiomems, 2nd Gen Centrimag Primary Console, Optis |
| Astrazeneca Pharmaceuticals LP | $1,192.16 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Amgen INC. | $1,180.81 | 2019-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $1,166.46 | 2019-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve, Pascal |
| Merck Sharp & Dohme LLC | $1,071.79 | 2022-2025 | Verquvo, Winrevair, Capvaxive |
| Actelion Pharmaceuticals US, INC. | $961.23 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Abiomed | $847.53 | 2019-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $772.97 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $751.04 | 2019-2025 | Watchman Flx, Watchman Access System, Rotablator Rotational Atherectomy System Console Kit |
| E.R. Squibb & Sons, L.L.C. | $713.32 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $667.53 | 2019-2024 | Xarelto |
| Esperion Therapeutics, INC. | $632.31 | 2020-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $628.55 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $603.80 | 2019-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $480.34 | 2019-2025 | Ffrct |
| United Therapeutics Corporation | $437.34 | 2019-2025 | Orenitram, Tyvaso, Tyvaso |
| Pfizer INC. | $428.13 | 2019-2025 | |
| Medtronic Vascular, INC. | $358.13 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $351.67 | 2019-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $294.31 | 2019-2024 | |
| Amarin Pharma, INC. | $231.69 | 2019-2021 | |
| Shockwave Medical, INC | $209.99 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $192.12 | 2023-2024 | Evkeeza |
| Atricure, INC. | $144.76 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Lexicon Pharmaceuticals, INC. | $120.64 | 2023-2024 | Inpefa |
| Alnylam Pharmaceuticals INC. | $111.99 | 2020-2025 | Amvuttra |
| Impulse Dynamics (USA) INC. | $101.84 | 2022-2023 | Optimizer |
| Cathworks, INC. | $98.35 | 2019-2021 | |
| Lundbeck LLC | $88.85 | 2019-2021 | |
| Scpharmaceuticals INC. | $70.40 | 2025 | |
| Bridgebio Pharma, INC. | $44.19 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $43.23 | 2024 | Arcalyst |
| Chiesi USA, INC. | $38.58 | 2024-2025 | Kengreal |
| Irhythm Technologies, INC. | $37.55 | 2019-2022 | |
| Portola Pharmaceuticals, LLC | $35.51 | 2019 | |
| Kestra Medical Technology Services, INC. | $32.56 | 2023-2024 | Assure Wcd |
| Terumo Medical Corporation | $30.00 | 2023 | Azur Cx Detachable, Angio-Seal |
| Lantheus Medical Imaging, INC. | $28.34 | 2023 | Definity |
| Medicomp INC | $27.14 | 2021 | |
| Lilly USA, LLC | $22.85 | 2025 | Zepbound |
| Siemens Medical Solutions USA, INC. | $17.09 | 2019 | |
| Ekos Corporation | $15.52 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.04 | 2019 | |
| Novo Nordisk INC | $13.85 | 2023 | Ozempic, Rybelsus |
| Aegerion Pharmaceuticals, INC. | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Dhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.